Herbalife (HLF) Expected to Announce Earnings on Wednesday

Herbalife (NYSE:HLF) is projected to issue its Q4 2025 results after the market closes on Wednesday, February 18th. Analysts expect the company to announce earnings of $0.43 per share and revenue of $1.2442 billion for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Wednesday, February 18, 2026 at 5:30 PM ET.

Herbalife Stock Down 1.2%

NYSE HLF opened at $15.88 on Monday. The company’s 50 day moving average is $15.18 and its 200-day moving average is $11.46. Herbalife has a 12-month low of $5.50 and a 12-month high of $17.93. The firm has a market cap of $1.64 billion, a P/E ratio of 5.07 and a beta of 0.84.

Insider Transactions at Herbalife

In other Herbalife news, Director Lynda Cloud bought 17,000 shares of the firm’s stock in a transaction on Tuesday, November 18th. The shares were acquired at an average cost of $8.97 per share, for a total transaction of $152,490.00. Following the purchase, the director directly owned 38,857 shares of the company’s stock, valued at $348,547.29. The trade was a 77.78% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders acquired a total of 18,200 shares of company stock worth $167,938 over the last three months. 1.73% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Manatuck Hill Partners LLC lifted its position in Herbalife by 122.2% during the third quarter. Manatuck Hill Partners LLC now owns 1,000,000 shares of the company’s stock valued at $8,440,000 after purchasing an additional 550,000 shares during the last quarter. Invesco Ltd. raised its position in shares of Herbalife by 60.5% during the 3rd quarter. Invesco Ltd. now owns 763,857 shares of the company’s stock valued at $6,447,000 after buying an additional 287,880 shares in the last quarter. UBS Group AG lifted its holdings in shares of Herbalife by 74.3% during the 3rd quarter. UBS Group AG now owns 658,654 shares of the company’s stock worth $5,559,000 after acquiring an additional 280,870 shares during the last quarter. Solel Partners LP lifted its holdings in shares of Herbalife by 18.7% during the 2nd quarter. Solel Partners LP now owns 1,669,405 shares of the company’s stock worth $14,390,000 after acquiring an additional 262,614 shares during the last quarter. Finally, Counterpoint Mutual Funds LLC purchased a new position in Herbalife in the fourth quarter worth $3,368,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on HLF shares. Weiss Ratings reissued a “hold (c)” rating on shares of Herbalife in a report on Thursday, January 22nd. Citigroup reiterated a “buy” rating and set a $17.00 price objective (up from $11.00) on shares of Herbalife in a research note on Friday, December 12th. Maxim Group began coverage on Herbalife in a report on Tuesday, January 6th. They set a “buy” rating and a $20.00 price objective on the stock. Wall Street Zen raised Herbalife from a “hold” rating to a “buy” rating in a report on Friday, November 28th. Finally, Argus set a $15.00 price target on Herbalife in a research report on Wednesday, November 26th. Four investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Herbalife presently has a consensus rating of “Moderate Buy” and an average price target of $15.80.

About Herbalife

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.